<HTML>
<HEAD>
<BASE TARGET="_top">
<TITLE>Patent Database Search Results:  ((ttl/aspirin or abst/aspirin)) in US Patent Collection</TITLE>
<script language="javascript">
var clicked = false;
// Shamelessly adapted from http://www.randomsnippets.com/2008/02/21/how-to-dynamically-add-form-elements-via-javascript/ 09-04-14. jh
function addInput(divName,btnName,btnLabel) {
   var newdiv = document.createElement('div');
   newdiv.innerHTML = "<input type='hidden' name='" + btnName +
			"' value='" + btnLabel + "'>";
   divName.appendChild(newdiv);
}
// -- 09-04-14.
function check(form1,formBtn) {
   // if submitted by <enter> key, add a submit button lookalike to prevent
   // 1003 errs from BRS. 9-4-14 jh
   if (!clicked)
      addInput (form1,formBtn.name,formBtn.value);
   return true;
}
function unesc(){
   srchForm.Srch1.value = unescape(srchForm.Srch1.value);
   if (srchForm.Srch2)
      srchForm.Srch2.value = unescape(srchForm.Srch2.value);
}
function unesc2(){
   srchForm2.Srch1.value = unescape(srchForm2.Srch1.value);
   if (srchForm2.Srch2)
      srchForm2.Srch2.value = unescape(srchForm2.Srch2.value);
}
function decod(){
   document.title = decodeURIComponent(document.title);
   refine.Query.value = decodeURIComponent(refine.Query.value);
   var x = document.getElementById("srchtext").childNodes[0];
   x.data = decodeURIComponent(x.data);
}
</script>
</HEAD>
<BODY BGCOLOR="#FFFFFF" onload="decod()">
<center>
<IMG SRC="/netaicon/PTO/patfthdr.gif" alt="[US Patent & Trademark Office, Patent Full Text and Image Database]">
<br>
<a name="top">
<table>
<tr><td>
<a href="/netahtml/PTO/index.html"><img src="/netaicon/PTO/home.gif" alt="[Home]" border="0"></a>
<a href="/netahtml/PTO/search-bool.html"><img src="/netaicon/PTO/boolean.gif" alt="[Boolean Search]" border="0"></a>
<A HREF="/netahtml/PTO/search-adv.htm"><img src="/netaicon/PTO/manual.gif" alt="[Manual Search]" border="0"></A>
<a href="/netahtml/PTO/srchnum.htm"><img src="/netaicon/PTO/number.gif" alt="[Number Search]" border="0"></a>
<A HREF="/netahtml/PTO/help/help.htm"><IMG BORDER="0"SRC="/netaicon/PTO/help.gif" ALT="[Help]"></A>
</td></tr>
</table>
<A HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=0&p=1&f=S&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&Page=Prev&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)><IMG ALIGN=MIDDLE SRC=/netaicon/PTO/prevlist.gif border=0 ALT=[PREV_LIST]></A>
<A HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=0&p=3&f=S&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&Page=Next&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)><IMG ALIGN=MIDDLE SRC=/netaicon/PTO/nextlist.gif border=0 ALT=[NEXT_LIST]></A>
<a href="#bottom"><img src="/netaicon/PTO/bottom.gif" alt="[Bottom]" align=middle border="0"></a>
<A HREF="https://certifiedcopycenter.uspto.gov/other/patft/view.html?backUrl1=http%3A//patft.uspto.gov/netacgi/nph-Parser?Sect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv.htm%26r%3D0%26p%3D2%26f%3DS%26l%3D50%26d%3DPTXT%26S1%3D(aspirin.TI.%252BOR%252Baspirin.ABTX.)%26Page%3DNext%26OS%3D%252B((ttl%2Faspirin%252Bor%252Babst%2Faspirin))%26RS%3D(TTL%2Faspirin%252BOR%252BABST%2Faspirin)&backLabel1=Back%20to%20Document%3A%20 ((ttl/aspirin or abst/aspirin))"><img src="/netaicon/PTO/cart.gif" align=middle border=0 alt="[View Shopping Cart]"></A>
</center>
<p>
<i>Searching US Patent Collection...</i><BR></p>
<B>Results of Search in US Patent Collection db for:<BR> <span id="srchtext">(TTL/aspirin OR ABST/aspirin)</span></B>: 291 patents.
<BR><I>Hits <strong>51</strong> through <strong>100
</strong> out of <strong>291</strong>
</I><p>

<BR>
<form name="srchForm" action="/netacgi/nph-Parser" method="GET" onsubmit="unesc()">
    <INPUT TYPE="HIDDEN" NAME="Sect1" VALUE="PTO2">
    <INPUT TYPE="HIDDEN" NAME="Sect2" VALUE="HITOFF">
    <INPUT TYPE="HIDDEN" NAME="u" VALUE="/netahtml/PTO/search-adv.htm">
    <INPUT TYPE="HIDDEN" NAME="r" VALUE="0">
    <INPUT TYPE="HIDDEN" NAME="f" VALUE="S">
    <INPUT TYPE="HIDDEN" NAME="l" VALUE="50">
    <INPUT TYPE="HIDDEN" NAME="d" VALUE="PTXT">
    <INPUT TYPE="HIDDEN" NAME="OS" VALUE=" ((ttl/aspirin or abst/aspirin))">
    <INPUT TYPE="HIDDEN" NAME="RS" VALUE="(TTL/aspirin OR ABST/aspirin)">
    <INPUT TYPE="HIDDEN" NAME="Query" VALUE=" ((ttl/aspirin or abst/aspirin))">
<INPUT TYPE=submit NAME=PrevList1 VALUE="Prev. 50 Hits"><BR><BR>
<INPUT TYPE="HIDDEN" NAME="TD" VALUE="291">
<INPUT TYPE="HIDDEN" NAME="Srch1" VALUE="(aspirin.TI. OR aspirin.ABTX.)">
<INPUT TYPE=submit NAME=NextList3 VALUE="Next 50 Hits"><BR><BR>
</FORM>
<form name="srchForm2" action="/netacgi/nph-Parser" method="GET"
	onsubmit="unesc2();check(this,this.StartAt)">
    <INPUT TYPE="HIDDEN" NAME="Sect1" VALUE="PTO2">
    <INPUT TYPE="HIDDEN" NAME="Sect2" VALUE="HITOFF">
    <INPUT TYPE="HIDDEN" NAME="u" VALUE="/netahtml/PTO/search-adv.htm">
    <INPUT TYPE="HIDDEN" NAME="r" VALUE="0">
    <INPUT TYPE="HIDDEN" NAME="f" VALUE="S">
    <INPUT TYPE="HIDDEN" NAME="l" VALUE="50">
    <INPUT TYPE="HIDDEN" NAME="d" VALUE="PTXT">
    <INPUT TYPE="HIDDEN" NAME="RS" VALUE="(TTL/aspirin OR ABST/aspirin)">
    <INPUT TYPE="HIDDEN" NAME="Query" VALUE=" ((ttl/aspirin or abst/aspirin))">
<INPUT TYPE="HIDDEN" NAME="TD" VALUE="291">
<INPUT TYPE="HIDDEN" NAME="Srch1" VALUE="(aspirin.TI. OR aspirin.ABTX.)">

<INPUT TYPE=submit name=StartAt VALUE="Jump To" onclick="clicked=true;">
&nbsp;
<INPUT size=6 name="StartNum" title="Record Number">	<!-- 2/21/14 508 -->
</form>
<BR><BR>
<form name="refine" action="/netacgi/nph-Parser" method="GET" onsubmit="check(this,this.Refine)">
    <INPUT TYPE="HIDDEN" NAME="Sect1" VALUE="PTO2">
    <INPUT TYPE="HIDDEN" NAME="Sect2" VALUE="HITOFF">
    <INPUT TYPE="HIDDEN" NAME="u" VALUE="/netahtml/PTO/search-adv.htm">
    <INPUT TYPE="HIDDEN" NAME="r" VALUE="0">
    <INPUT TYPE="HIDDEN" NAME="f" VALUE="S">
    <INPUT TYPE="HIDDEN" NAME="l" VALUE="50">
    <INPUT TYPE="HIDDEN" NAME="d" VALUE="PTXT">
    <INPUT TYPE="HIDDEN" NAME="RS" VALUE="(TTL/aspirin OR ABST/aspirin)">
<INPUT type="submit" name="Refine" value="Refine Search" onclick="clicked=true;">
<INPUT size=50 name="Query" value=" ((ttl/aspirin or abst/aspirin))" title="Query">	<!-- 2/21/14 508 -->
</FORM>
<TABLE><TR><TD></TD><TH scope="col">PAT. NO.</TH><TD></TD><TH scope="col">Title</TH></TR>
<TR><TD valign=top>51</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=51&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>8,168,400</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=51&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Methods and kits for detection of thromboxane A2 metabolites
</A></TD>
<DOCS: 291>
<TR><TD valign=top>52</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=52&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>8,148,416</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=52&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Treatment of inflammatory, cancer, and thrombosis disorders
</A></TD>
<DOCS: 291>
<TR><TD valign=top>53</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=53&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>8,105,790</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=53&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Methods and kits for detection of thromboxane A2 metabolites
</A></TD>
<DOCS: 291>
<TR><TD valign=top>54</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=54&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>8,057,820</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=54&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Enteric coated aspirin granules comingled with binder
</A></TD>
<DOCS: 291>
<TR><TD valign=top>55</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=55&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>8,043,826</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=55&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Device for monitoring inhibition of platelet function response
</A></TD>
<DOCS: 291>
<TR><TD valign=top>56</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=56&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>8,022,105</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=56&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Prevention of neutrophil recruitment
</A></TD>
<DOCS: 291>
<TR><TD valign=top>57</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=57&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>8,017,368</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=57&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Molecular delivery to cells using aspirin-related compounds
</A></TD>
<DOCS: 291>
<TR><TD valign=top>58</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=58&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,964,220</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=58&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Method for treating a mammal by administration of a compound having the
     ability to release CO
</A></TD>
<DOCS: 291>
<TR><TD valign=top>59</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=59&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,935,498</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=59&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Methods for identifying patients with increased risk of an adverse
     cardiovascular event
</A></TD>
<DOCS: 291>
<TR><TD valign=top>60</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=60&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,872,152</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=60&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Use of docosatrienes, resolvins and their stable analogs in the treatment
     of airway diseases and asthma
</A></TD>
<DOCS: 291>
<TR><TD valign=top>61</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=61&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,855,200</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=61&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Method for treatment of gastric ulcers and ulcers induced by aspirin
</A></TD>
<DOCS: 291>
<TR><TD valign=top>62</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=62&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,833,793</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=62&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Method and device for monitoring inhibition of platelet function
</A></TD>
<DOCS: 291>
<TR><TD valign=top>63</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=63&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,785,891</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=63&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Device and methods for identifying and treating aspirin non-responsive
     patients
</A></TD>
<DOCS: 291>
<TR><TD valign=top>64</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=64&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,767,646</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=64&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Methods of screening for compounds that modulate TAFIa activity,
     compounds, and methods of using the compounds
</A></TD>
<DOCS: 291>
<TR><TD valign=top>65</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=65&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,759,395</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=65&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Use of docosatrienes, resolvins and their stable analogs in the treatment
     of airway diseases and asthma
</A></TD>
<DOCS: 291>
<TR><TD valign=top>66</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=66&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,737,178</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=66&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Aspirin-triggered lipid mediators
</A></TD>
<DOCS: 291>
<TR><TD valign=top>67</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=67&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,727,730</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=67&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Methods and kits for detection of thromboxane A2 metabolites
</A></TD>
<DOCS: 291>
<TR><TD valign=top>68</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=68&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,709,669</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=68&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Aspirin-triggered lipid mediators
</A></TD>
<DOCS: 291>
<TR><TD valign=top>69</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=69&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,682,637</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=69&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Efficient method for producing compositions enriched in total phenols
</A></TD>
<DOCS: 291>
<TR><TD valign=top>70</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=70&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,622,502</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=70&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as
     cyclooxygenase-2 inhibitors
</A></TD>
<DOCS: 291>
<TR><TD valign=top>71</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=71&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,622,501</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=71&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as
     cyclooxygenase-2 inhibitors
</A></TD>
<DOCS: 291>
<TR><TD valign=top>72</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=72&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,618,955</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=72&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Association of an antithrombotic and aspirin
</A></TD>
<DOCS: 291>
<TR><TD valign=top>73</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=73&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,615,576</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=73&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Prevention of neutrophil recruitment
</A></TD>
<DOCS: 291>
<TR><TD valign=top>74</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=74&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,614,496</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=74&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Aqueous solution of an analgesic and a dispenser therefor
</A></TD>
<DOCS: 291>
<TR><TD valign=top>75</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=75&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,598,233</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=75&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Method for treating thrombosis
</A></TD>
<DOCS: 291>
<TR><TD valign=top>76</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=76&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,585,856</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=76&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Resolvins: Biotemplates for novel therapeutic interventions
</A></TD>
<DOCS: 291>
<TR><TD valign=top>77</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=77&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,579,494</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=77&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Prevention of neutrophil recruitment
</A></TD>
<DOCS: 291>
<TR><TD valign=top>78</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=78&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,439,077</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=78&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Coumarin analog compounds for safer anticoagulant treatment
</A></TD>
<DOCS: 291>
<TR><TD valign=top>79</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=79&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,419,960</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=79&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Hemiterpene glycosides with anti-platelet aggregation activities from Ilex
     pubescens
</A></TD>
<DOCS: 291>
<TR><TD valign=top>80</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=80&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,368,469</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=80&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Use of inhibitors of the renin-angiotensin system in the prevention of
     cardiovascular events
</A></TD>
<DOCS: 291>
<TR><TD valign=top>81</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=81&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,358,091</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=81&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Device and methods for identifying and treating aspirin non-responsive
     patients
</A></TD>
<DOCS: 291>
<TR><TD valign=top>82</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=82&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,338,971</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=82&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Treatment of inflammatory, cancer, and thrombosis disorders
</A></TD>
<DOCS: 291>
<TR><TD valign=top>83</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=83&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,252,208</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=83&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Tablet dispenser
</A></TD>
<DOCS: 291>
<TR><TD valign=top>84</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=84&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,227,031</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=84&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Prevention of neutrophil recruitment
</A></TD>
<DOCS: 291>
<TR><TD valign=top>85</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=85&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,205,115</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=85&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Method and system for stabilization of arachidonic acid for use in
     platelet function assay
</A></TD>
<DOCS: 291>
<TR><TD valign=top>86</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=86&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,202,229</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=86&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Aspirin formulation for cardiovascular health
</A></TD>
<DOCS: 291>
<TR><TD valign=top>87</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=87&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,201,929</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=87&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Aspirin formulation for cardiovascular health
</A></TD>
<DOCS: 291>
<TR><TD valign=top>88</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=88&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,199,154</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=88&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as
     cyclooxygenase-2 inhibitors
</A></TD>
<DOCS: 291>
<TR><TD valign=top>89</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=89&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,179,838</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=89&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Coumarin analog compounds for safer anticoagulant treatment
</A></TD>
<DOCS: 291>
<TR><TD valign=top>90</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=90&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,169,809</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=90&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as
     cyclooxygenase-2 inhibitors
</A></TD>
<DOCS: 291>
<TR><TD valign=top>91</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=91&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,132,451</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=91&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Inhibition of TNF-.alpha.-initiated neutrophil response
</A></TD>
<DOCS: 291>
<TR><TD valign=top>92</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=92&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,119,068</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=92&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Methods of screening for compounds that modulate TAFIa activity,
     compounds, and methods of using the compounds
</A></TD>
<DOCS: 291>
<TR><TD valign=top>93</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=93&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,109,206</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=93&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Methods and compositions for the rapid and enduring relief of inadequate
     myocardial function
</A></TD>
<DOCS: 291>
<TR><TD valign=top>94</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=94&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,081,347</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=94&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Method for predicting cardiovascular events
</A></TD>
<DOCS: 291>
<TR><TD valign=top>95</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=95&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,053,230</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=95&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Aspirin-triggered lipid mediators
</A></TD>
<DOCS: 291>
<TR><TD valign=top>96</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=96&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,041,286</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=96&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Composition for mitigating a pernicious thrombotic event
</A></TD>
<DOCS: 291>
<TR><TD valign=top>97</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=97&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,033,618</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=97&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Methods of administering gaultherin-containing compositions
</A></TD>
<DOCS: 291>
<TR><TD valign=top>98</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=98&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,029,701</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=98&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Composition for the treatment and prevention of ischemic events
</A></TD>
<DOCS: 291>
<TR><TD valign=top>99</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=99&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,029,663</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=99&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Stable ointment containing acetylsalicylic acid
</A></TD>
<DOCS: 291>
<TR><TD valign=top>100</TD>
<TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=100&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>7,015,247</A></TD>
     <TD valign=baseline><IMG border=0 src="/netaicon/PTO/ftext.gif" alt="Full-Text"></TD>
     <TD valign=top><A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=100&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)>Ibuprofen-aspirin, hydroxymethylacylfulvene analogs and L-sugar illudin
     analogs
</A></TD>
   </TABLE><HR><br>
   <center>
   <table>
   <tr><td><A HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=0&p=1&f=S&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&Page=Prev&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)><IMG ALIGN=MIDDLE SRC=/netaicon/PTO/prevlist.gif border=0 ALT=[PREV_LIST]></A>
<A HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=0&p=3&f=S&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&Page=Next&OS=+((ttl/aspirin+or+abst/aspirin))&RS=(TTL/aspirin+OR+ABST/aspirin)><IMG ALIGN=MIDDLE SRC=/netaicon/PTO/nextlist.gif border=0 ALT=[NEXT_LIST]></A>
<a name="bottom"><a href="#top"><img src="/netaicon/PTO/top.gif" alt="[Top]" border="0" align=middle></a>
   <A HREF="https://certifiedcopycenter.uspto.gov/other/patft/view.html?backUrl1=http%3A//patft.uspto.gov/netacgi/nph-Parser?Sect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%252Fnetahtml%252FPTO%252Fsearch-adv.htm%26r%3D0%26p%3D2%26f%3DS%26l%3D50%26d%3DPTXT%26S1%3D(aspirin.TI.%252BOR%252Baspirin.ABTX.)%26Page%3DNext%26OS%3D%252B((ttl%2Faspirin%252Bor%252Babst%2Faspirin))%26RS%3D(TTL%2Faspirin%252BOR%252BABST%2Faspirin)&backLabel1=Back%20to%20Document%3A%20 ((ttl/aspirin or abst/aspirin))"><img border=0 src="/netaicon/PTO/cart.gif" alt="[View Shopping Cart]" border = "0" align
=middle></A>
   </td></tr>
   </table>
   <a href="/netahtml/PTO/index.html"><img src="/netaicon/PTO/home.gif" alt="[Home]" border="0" valign=baseline></a>
   <a href="/netahtml/PTO/search-bool.html"><img src="/netaicon/PTO/boolean.gif" alt="[Boolean Search]" border="0" valign=baseline></a>
   <A HREF="/netahtml/PTO/search-adv.htm"><img src="/netaicon/PTO/manual.gif" alt="[Manual Search]" border="0" valign=baseline></A>
   <a href="/netahtml/PTO/srchnum.htm"><img src="/netaicon/PTO/number.gif" alt="[Number Search]" border="0" valign=baseline></a>
   <A HREF="/netahtml/PTO/help/help.htm"><img border="0" src="/netaicon/PTO/help.gif" ALT="[Help]" border="0" valign=baseline></A>
   </center>
   </HTML>